Vanguard Group
ELOX

Vanguard Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,786
Closed -$100K 4597
2023
Q3
$100K Buy
20,786
+100
+0.5% +$481 ﹤0.01% 4347
2023
Q2
$80.5K Hold
20,686
﹤0.01% 4408
2023
Q1
$51.9K Sell
20,686
-19,727
-49% -$49.5K ﹤0.01% 4464
2022
Q4
$73.6K Sell
40,413
-2,664,100
-99% -$4.85M ﹤0.01% 4417
2022
Q3
$459K Sell
2,704,513
-117,680
-4% -$20K ﹤0.01% 4241
2022
Q2
$762K Hold
2,822,193
﹤0.01% 4173
2022
Q1
$1.58M Sell
2,822,193
-215,296
-7% -$121K ﹤0.01% 4054
2021
Q4
$2.14M Sell
3,037,489
-9,549
-0.3% -$6.74K ﹤0.01% 4006
2021
Q3
$4.97M Sell
3,047,038
-8,479
-0.3% -$13.8K ﹤0.01% 3666
2021
Q2
$6.08M Buy
3,055,517
+1,862,820
+156% +$3.71M ﹤0.01% 3487
2021
Q1
$3.96M Buy
1,192,697
+15,091
+1% +$50.1K ﹤0.01% 3649
2020
Q4
$4.69M Buy
1,177,606
+14,041
+1% +$55.9K ﹤0.01% 3388
2020
Q3
$3.06M Sell
1,163,565
-11,090
-0.9% -$29.2K ﹤0.01% 3354
2020
Q2
$3.56M Buy
1,174,655
+23,953
+2% +$72.6K ﹤0.01% 3244
2020
Q1
$2.26M Buy
1,150,702
+9,643
+0.8% +$18.9K ﹤0.01% 3269
2019
Q4
$8.4M Buy
1,141,059
+4,696
+0.4% +$34.6K ﹤0.01% 2944
2019
Q3
$5.14M Buy
1,136,363
+42,609
+4% +$193K ﹤0.01% 3131
2019
Q2
$10.9M Buy
1,093,754
+86,124
+9% +$859K ﹤0.01% 2809
2019
Q1
$11.8M Buy
1,007,630
+42,416
+4% +$495K ﹤0.01% 2741
2018
Q4
$11.6M Buy
965,214
+108,012
+13% +$1.3M ﹤0.01% 2703
2018
Q3
$14.6M Buy
857,202
+321,328
+60% +$5.48M ﹤0.01% 2739
2018
Q2
$9.15M Buy
+535,874
New +$9.15M ﹤0.01% 2945